• Profile
Close

Multimorbidity, glycaemic variability and time in target range in people with type 2 diabetes: A baseline analysis of the GP-OSMOTIC trial

Diabetes Research and Clinical Practice Sep 20, 2020

Chiang JI, Manski-Nankervis JA, Thuraisingam S, et al. - Researchers conducted this cross-sectional study to explore correlations between multimorbidity condition counts (total; concordant (diabetes-related); discordant (unrelated to diabetes)) and glycaemia (HbA1c; glycaemic variability (GV); time in range (TIR)) using data from a randomised controlled trial investigating the effectiveness of continuous glucose monitoring (CGM) in people with type 2 diabetes (T2D). Two hundred seventy-nine people, mean (SD) age 60.4 (9.9) years, with T2D using baseline data from the General Practice Optimising Structured MOnitoring To Improve Clinical outcomes (GP-OSMOTIC) trial from 25 general practices in Australia. No proof of interaction between multimorbidity counts, HbA1c, GV and TIR. Although multimorbidity was common in this T2D cohort, it was not linked to HbA1c, CV or TIR. 

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay